AwesomeCapital
Search This Blog
Wednesday, June 6, 2018
Ironwood gets FDA orphan status for sickle cell med
The FDA granted Ironwood Pharmaceuticals orphan status for olinciguat, its treatment of sickle cell disease.
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=639718
https://bit.ly/2HqLyuD
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.